Skip to main content
Top
Published in: European Radiology 7/2019

01-07-2019 | Metastasis | Breast

Radiomic nomogram for prediction of axillary lymph node metastasis in breast cancer

Authors: Lu Han, Yongbei Zhu, Zhenyu Liu, Tao Yu, Cuiju He, Wenyan Jiang, Yangyang Kan, Di Dong, Jie Tian, Yahong Luo

Published in: European Radiology | Issue 7/2019

Login to get access

Abstract

Objective

To develop a radiomic nomogram for preoperative prediction of axillary lymph node (LN) metastasis in breast cancer patients.

Methods

Preoperative magnetic resonance imaging data from 411 breast cancer patients was studied. Patients were assigned to either a training cohort (n = 279) or a validation cohort (n = 132). Eight hundred eight radiomic features were extracted from the first phase of T1-DCE images. A support vector machine was used to develop a radiomic signature, and logistic regression was used to develop a nomogram.

Results

The radiomic signature based on 12 LN status–related features was constructed to predict LN metastasis, its prediction ability was moderate, with an area under the curve (AUC) of 0.76 and 0.78 in training and validation cohorts, respectively. Based on a radiomic signature and clinical features, a nomogram was developed and showed excellent predictive ability for LN metastasis (AUC 0.84 and 0.87 in training and validation sets, respectively). Another radiomic signature was constructed to distinguish the number of metastatic LNs (less than 2 positive nodes/more than 2 positive nodes), which also showed moderate performance (AUC 0.79).

Conclusions

We developed a nomogram and a radiomic signature that can be used to identify LN metastasis and distinguish the number of metastatic LNs (less than 2 positive nodes/more than 2 positive nodes). Both nomogram and radiomic signature can be used as tools to assist clinicians in assessing LN metastasis in breast cancer patients.

Key Points

ALNM is an important factor affecting breast cancer patients’ treatment and prognosis.
Traditional imaging examinations have limited value for evaluating axillary LNs status.
We developed a radiomic nomogram based on MR imagings to predict LN metastasis.
Literature
1.
go back to reference Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in globocan 2012. Int J Cancer 136:E359CrossRefPubMed Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in globocan 2012. Int J Cancer 136:E359CrossRefPubMed
2.
go back to reference Lu S, Huang X, Yu H et al (2016) Dietary patterns and risk of breast cancer in Chinese women: a population-based case-control study. Lancet 388:S61CrossRef Lu S, Huang X, Yu H et al (2016) Dietary patterns and risk of breast cancer in Chinese women: a population-based case-control study. Lancet 388:S61CrossRef
3.
go back to reference Weigel MT, Dowsett M (2010) Current and emerging biomarkers in breast cancer: prognosis and prediction. Endocr Relat Cancer 17:R245–R262CrossRefPubMed Weigel MT, Dowsett M (2010) Current and emerging biomarkers in breast cancer: prognosis and prediction. Endocr Relat Cancer 17:R245–R262CrossRefPubMed
4.
go back to reference Gherghe M, Bordea C, Blidaru A (2015) Sentinel lymph node biopsy (SLNB) vs axillary lymph node dissection (ALND) in the current surgical treatment of early stage breast cancer. J Med Life 8:176–180PubMedPubMedCentral Gherghe M, Bordea C, Blidaru A (2015) Sentinel lymph node biopsy (SLNB) vs axillary lymph node dissection (ALND) in the current surgical treatment of early stage breast cancer. J Med Life 8:176–180PubMedPubMedCentral
5.
go back to reference Sakorafas GH, Peros G, Cataliotti L, Vlastos G (2006) Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 15:153–165CrossRefPubMed Sakorafas GH, Peros G, Cataliotti L, Vlastos G (2006) Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 15:153–165CrossRefPubMed
6.
go back to reference Warmuth MA, Bowen G, Prosnitz LR et al (2015) Complications of axillary lymph node dissection for carcinoma of the breast. Cancer 83:1362–1368CrossRef Warmuth MA, Bowen G, Prosnitz LR et al (2015) Complications of axillary lymph node dissection for carcinoma of the breast. Cancer 83:1362–1368CrossRef
7.
go back to reference McMasters KM, Tuttle TM, Carlson DJ et al (2000) Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 18:2560–2566CrossRefPubMed McMasters KM, Tuttle TM, Carlson DJ et al (2000) Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 18:2560–2566CrossRefPubMed
8.
go back to reference Schrenk P, Rieger R, Shamiyeh A, Wayand W (2000) Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88:608–614CrossRefPubMed Schrenk P, Rieger R, Shamiyeh A, Wayand W (2000) Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88:608–614CrossRefPubMed
9.
go back to reference Kvistad KA, Rydland J, Smethurst HB, Lundgren S, Fjøsne HE, Haraldseth O (2000) Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI. Eur Radiol 10:1464–1471CrossRefPubMed Kvistad KA, Rydland J, Smethurst HB, Lundgren S, Fjøsne HE, Haraldseth O (2000) Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI. Eur Radiol 10:1464–1471CrossRefPubMed
10.
go back to reference Valente SA, Levine GM, Silverstein MJ et al (2012) Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging. Ann Surg Oncol 19:1825–1830CrossRefPubMed Valente SA, Levine GM, Silverstein MJ et al (2012) Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging. Ann Surg Oncol 19:1825–1830CrossRefPubMed
11.
go back to reference An YS, Lee DH, Yoon JK et al (2014) Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI detection of axillary lymph node metastasis in breast cancer patients. Nuklearmedizin 53:89–94CrossRefPubMed An YS, Lee DH, Yoon JK et al (2014) Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI detection of axillary lymph node metastasis in breast cancer patients. Nuklearmedizin 53:89–94CrossRefPubMed
12.
go back to reference Zhang YN, Wang CJ, Xu Y et al (2015) Sensitivity, specificity and accuracy of ultrasound in diagnosis of breast cancer metastasis to the axillary lymph nodes in Chinese patients. Ultrasound Med Biol 41:1835–1841CrossRefPubMed Zhang YN, Wang CJ, Xu Y et al (2015) Sensitivity, specificity and accuracy of ultrasound in diagnosis of breast cancer metastasis to the axillary lymph nodes in Chinese patients. Ultrasound Med Biol 41:1835–1841CrossRefPubMed
13.
go back to reference Hwang SO, Lee SW, Kim HJ, Wan WK, Park HY, Jin HJ (2013) The comparative study of ultrasonography, contrast-enhanced MRI, and 18F-FDG PET/CT for detecting axillary lymph node metastasis in T1 breast cancer. J Breast Cancer 16:315–321CrossRefPubMedPubMedCentral Hwang SO, Lee SW, Kim HJ, Wan WK, Park HY, Jin HJ (2013) The comparative study of ultrasonography, contrast-enhanced MRI, and 18F-FDG PET/CT for detecting axillary lymph node metastasis in T1 breast cancer. J Breast Cancer 16:315–321CrossRefPubMedPubMedCentral
14.
go back to reference Diepstraten SC, Sever AR, Buckens CF et al (2014) Value of preoperative ultrasound-guided axillary lymph node biopsy for preventing completion axillary lymph node dissection in breast cancer: a systematic review and meta-analysis. Ann Surg Oncol 21:51–59CrossRefPubMed Diepstraten SC, Sever AR, Buckens CF et al (2014) Value of preoperative ultrasound-guided axillary lymph node biopsy for preventing completion axillary lymph node dissection in breast cancer: a systematic review and meta-analysis. Ann Surg Oncol 21:51–59CrossRefPubMed
15.
go back to reference Cooper KL, Meng Y, Harnan S et al (2011) Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation. Health Technol Assess 15:1–134CrossRefPubMedPubMedCentral Cooper KL, Meng Y, Harnan S et al (2011) Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation. Health Technol Assess 15:1–134CrossRefPubMedPubMedCentral
16.
go back to reference Pilewskie M, Morrow M (2014) Applications for breast magnetic resonance imaging. Surg Oncol Clin N Am 23:431–449CrossRefPubMed Pilewskie M, Morrow M (2014) Applications for breast magnetic resonance imaging. Surg Oncol Clin N Am 23:431–449CrossRefPubMed
17.
go back to reference Mainiero MB, Lourenco A, Mahoney MC et al (2013) ACR appropriateness criteria breast cancer screening. J Am Coll Radiol 10:11–14CrossRefPubMed Mainiero MB, Lourenco A, Mahoney MC et al (2013) ACR appropriateness criteria breast cancer screening. J Am Coll Radiol 10:11–14CrossRefPubMed
18.
go back to reference Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577CrossRefPubMed Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577CrossRefPubMed
20.
go back to reference Lambin P, Rios-Velazquez E, Leijenaar R et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446CrossRefPubMedPubMedCentral Lambin P, Rios-Velazquez E, Leijenaar R et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446CrossRefPubMedPubMedCentral
21.
go back to reference Bickelhaupt S, Paech D, Kickingereder P et al (2017) Prediction of malignancy by a radiomic signature from contrast agent-free diffusion MRI in suspicious breast lesions found on screening mammography. J Magn Reson Imaging 46(2):604–616CrossRefPubMed Bickelhaupt S, Paech D, Kickingereder P et al (2017) Prediction of malignancy by a radiomic signature from contrast agent-free diffusion MRI in suspicious breast lesions found on screening mammography. J Magn Reson Imaging 46(2):604–616CrossRefPubMed
22.
go back to reference Chang RF, Chen HH, Chang YC, Huang CS, Chen JH, Lo CM (2016) Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI. Magn Reson Imaging 34:809–819CrossRefPubMed Chang RF, Chen HH, Chang YC, Huang CS, Chen JH, Lo CM (2016) Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI. Magn Reson Imaging 34:809–819CrossRefPubMed
23.
go back to reference Fan M, Wu G, Cheng H, Zhang J, Shao G, Li L (2017) Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients. Eur J Radiol 94:140–147 Fan M, Wu G, Cheng H, Zhang J, Shao G, Li L (2017) Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients. Eur J Radiol 94:140–147
24.
go back to reference Giuliano AE, Hunt KK, Ballman KV et al (2017) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575CrossRef Giuliano AE, Hunt KK, Ballman KV et al (2017) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575CrossRef
25.
go back to reference Lyman GH, Temin S, Edge SB et al (2014) Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol 32:1365–1383CrossRefPubMed Lyman GH, Temin S, Edge SB et al (2014) Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol 32:1365–1383CrossRefPubMed
26.
go back to reference Kim EJ, Kim SH, Kang BJ, Choi BG, Song BJ, Choi JJ (2014) Diagnostic value of breast MRI for predicting metastatic axillary lymph nodes in breast cancer patients: diffusion-weighted MRI and conventional MRI. Magn Reson Imaging 32:1230–1236CrossRefPubMed Kim EJ, Kim SH, Kang BJ, Choi BG, Song BJ, Choi JJ (2014) Diagnostic value of breast MRI for predicting metastatic axillary lymph nodes in breast cancer patients: diffusion-weighted MRI and conventional MRI. Magn Reson Imaging 32:1230–1236CrossRefPubMed
27.
go back to reference van Griethuysen JJM, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Cancer Res 77:e104–e107 van Griethuysen JJM, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Cancer Res 77:e104–e107
28.
go back to reference Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ (2012) WHO classification of tumours of the breast. International Agency for Research on Cancer, Lyon Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ (2012) WHO classification of tumours of the breast. International Agency for Research on Cancer, Lyon
29.
go back to reference Bevilacqua JL, Kattan MW, Fey JV, Cody HS 3rd, Borgen PI, Van Zee KJ (2007) Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol 25:3670–3679 Bevilacqua JL, Kattan MW, Fey JV, Cody HS 3rd, Borgen PI, Van Zee KJ (2007) Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol 25:3670–3679
30.
go back to reference Viale G, Zurrida S, Maiorano E et al (2005) Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer 103:492–500CrossRefPubMed Viale G, Zurrida S, Maiorano E et al (2005) Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer 103:492–500CrossRefPubMed
31.
go back to reference Wu JL, Tseng HS, Yang LH et al (2014) Prediction of axillary lymph node metastases in breast cancer patients based on pathologic information of the primary tumor. Med Sci Monit 20:577–581CrossRefPubMedPubMedCentral Wu JL, Tseng HS, Yang LH et al (2014) Prediction of axillary lymph node metastases in breast cancer patients based on pathologic information of the primary tumor. Med Sci Monit 20:577–581CrossRefPubMedPubMedCentral
32.
go back to reference Dong Y, Feng Q, Yang W et al (2018) Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI. Eur Radiol 28:582–591CrossRefPubMed Dong Y, Feng Q, Yang W et al (2018) Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI. Eur Radiol 28:582–591CrossRefPubMed
33.
go back to reference Xie F, Yang H, Wang S et al (2012) A logistic regression model for predicting axillary lymph node metastases in early breast carcinoma patients. Sensors (Basel) 12:9936–9950CrossRef Xie F, Yang H, Wang S et al (2012) A logistic regression model for predicting axillary lymph node metastases in early breast carcinoma patients. Sensors (Basel) 12:9936–9950CrossRef
Metadata
Title
Radiomic nomogram for prediction of axillary lymph node metastasis in breast cancer
Authors
Lu Han
Yongbei Zhu
Zhenyu Liu
Tao Yu
Cuiju He
Wenyan Jiang
Yangyang Kan
Di Dong
Jie Tian
Yahong Luo
Publication date
01-07-2019
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 7/2019
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-018-5981-2

Other articles of this Issue 7/2019

European Radiology 7/2019 Go to the issue